FRX Related Hot List

Feb 22, 2011 08:01 AM Forest Labs (FRX) to acquire Clinical Data (CLDA) for $30/share, may pay contingent consideration of up to $6/share

Jan 18, 2011 08:04 AM Forest Labs (FRX) Reports Q3 Adj-EPS of $1.34; Raises FY11 Outlook

Oct 19, 2010 08:05 AM Forest Labs (FRX) Reports Mixed Q2 Results; Raises FY11 EPS Guidance

Apr 7, 2010 04:05 PM FDA Panel Votes 10-5 Against Forest Labs' (FRX) Daxas

Jan 20, 2009 08:13 AM Forest Labs (FRX) Tops Q3 Views; Raises FY09 Outlook

Apr 15, 2008 07:54 AM Forest Laboratories (FRX) Tops Q4 Views Ex-Items, Guides FY09 Below The Street

Jan 15, 2008 07:56 AM Forest Laboratories (FRX) Tops Q3 Views; Boosts Guidance

Feb 6, 2007 05:35 PM Forest Labs Ends Faropenem Collaboration with Replidyne (RDYN)

Jan 16, 2007 08:14 AM Forest Laboratories (FRX) Reports Q3 Earnings, Guides Higher for FY

Oct 23, 2006 07:42 AM Replidyne (RDYN) and Forest Labs (FRX) Receive Non-Approvable Letter for Faropenem

Oct 17, 2006 08:14 AM Forest Labs (FRX) Tops Q2 EPS by 10c; Guides Above

Jul 18, 2006 08:03 AM Forest Laboratories (FRX) Reports Q1 EPS of $0.62, Guides Higher for Full-Year EPS

Jul 14, 2006 12:17 AM Forest Labs (FRX) Said Court Rules Its Lexapro Patent is Valid and Enforceable

Jun 19, 2006 02:01 PM Sepracor (SEPR) Spokeswomen 'No Comment' On Takeover Talk, Shares Surge

Jan 17, 2006 08:23 AM FRX Reports In-Line Q3 EPS; Revs Below

Sep 28, 2005 05:02 PM FRX and CYPB Said Phase III Milnacipran did not achieve statistical significance

Jul 25, 2005 12:33 PM FRX Said FDA Issues Non-Approvable letter Related to Namenda Label Expansion

May 2, 2005 08:51 AM NTII Receives $1.12M Royalty Payment

Apr 6, 2005 08:26 AM FRX warns for Q4

Mar 30, 2005 04:12 PM FRX Non-Approvable Letter for Social Anxiety Disorder Indication for Lexapro